Literature DB >> 28900802

Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications.

Nina Rogenhofer1, Lara R M Nienaber1, Lea C Amshoff2, Nadia Bogdanova2, David Petroff3, Peter Wieacker2, Christian J Thaler1, Arseni Markoff4.   

Abstract

PURPOSE: The aim of this study was to confirm the associated M2/ANXA5 carrier risk in women with placenta-mediated pregnancy complications (PMPC) and to test their male partners for such association. Further analysis evaluated the influence of maternal vs. paternal M2 alleles on miscarriage.
METHODS: Two hundred eighty-eight couples with preeclampsia (PE), intrauterine growth restriction (IUGR), or premature birth (PB) were recruited (n = 96 of each phenotype). The prevalence of the M2 haplotype was compared to two control cohorts. They included a group of women with a history of normal pregnancy without gestational pathology (Munich controls, n = 94) and a random population sample (PopGen controls, n = 533).
RESULTS: Significant association of M2 haplotype and pregnancy complications was confirmed for women and for couples, where prevalence was elevated from 15.4 to 23.8% (p < 0.001). Post hoc analyses demonstrated an association for IUGR and PB individually. A strong link between previous miscarriages and M2 carrier status was identified which may explain the predisposition to placental pregnancy complication. M2/ANXA5 appears to be a risk factor for adverse pregnancy outcomes related, but not limited to miscarriages, with similar prevalence in women and their male partners.
CONCLUSION: These findings support the proposed physiological function of ANXA5 as an embryonic anticoagulant that appears deficient in contiguous specter of thrombophilia-related pregnancy complications culminating more frequently in miscarriage in a maternal M2 carrier background.

Entities:  

Keywords:  Annexin A5; M2/ANXA5; Miscarriage; Placenta-mediated pregnancy complications; Pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28900802      PMCID: PMC5758464          DOI: 10.1007/s10815-017-1041-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  37 in total

1.  Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.

Authors:  J H Rand; X X Wu; H A Andree; C J Lockwood; S Guller; J Scher; P C Harpel
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

2.  Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population.

Authors:  Kai-Cheen Ang; Sushilnathan Kathirgamanathan; Ewe Seng Ch'ng; Yan-Yeow Lee; Anna-Liza Roslani; Bavanandan Naidu; Krishna Kumar; Ridzuan Abdullah; Siti-Nadiah Abdul Kadir; Narazah Mohd Yusoff; Wan Zaidah Abdullah; Nadja Bogdanova; Peter Wieacker; Arseni Markoff; Thean-Hock Tang
Journal:  J Assist Reprod Genet       Date:  2017-01-20       Impact factor: 3.412

3.  Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Authors:  Nadja Bogdanova; Arseni Markoff
Journal:  J Community Genet       Date:  2010-06-11

4.  Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele.

Authors:  A Markoff; S Gerdes; S Feldner; N Bogdanova; V Gerke; E Grandone
Journal:  Placenta       Date:  2010-10       Impact factor: 3.481

5.  The M2 haplotype in the ANXA5 gene is an independent risk factor for idiopathic small-for-gestational age newborns.

Authors:  G Tiscia; D Colaizzo; G Favuzzi; P Vergura; P Martinelli; M Margaglione; E Grandone
Journal:  Mol Hum Reprod       Date:  2012-06-07       Impact factor: 4.025

Review 6.  PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships.

Authors:  Michael Krawczak; Susanna Nikolaus; Huberta von Eberstein; Peter J P Croucher; Nour Eddine El Mokhtari; Stefan Schreiber
Journal:  Community Genet       Date:  2006

7.  Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2.

Authors:  Elena Chinni; Giovanni Luca Tiscia; Donatella Colaizzo; Patrizia Vergura; Maurizio Margaglione; Elvira Grandone
Journal:  Fertil Steril       Date:  2008-05-07       Impact factor: 7.329

8.  Functional characterization of annexin A5 gene promoter allelic variants.

Authors:  Giovanni Luca Tiscia; Elisabeth Dørum; Christiane Filion Myklebust; Elvira Grandone; Per Morten Sandset; Grethe Skretting
Journal:  Thromb Res       Date:  2016-06-14       Impact factor: 3.944

9.  Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion.

Authors:  Charalambos Demetriou; Sayeda Abu-Amero; Shawnelle White; Emma Peskett; Arseni Markoff; Philip Stanier; Gudrun E Moore; Lesley Regan
Journal:  Reprod Biomed Online       Date:  2015-07-17       Impact factor: 3.828

10.  Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome.

Authors:  Simon Fishel; Deborah Baker; Janine Elson; Maha Ragunath; Glenn Atkinson; Adel Shaker; Ahmed Omar; Rahnuma Kazem; Ashley Beccles; Ian A Greer
Journal:  EBioMedicine       Date:  2016-07-18       Impact factor: 8.143

View more
  2 in total

1.  Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF).

Authors:  Nina Rogenhofer; Arseni Markoff; Xenia Ennerst; Nadja Bogdanova; Christian Thaler
Journal:  J Assist Reprod Genet       Date:  2020-11-24       Impact factor: 3.412

2.  Placental secretome characterization identifies candidates for pregnancy complications.

Authors:  Tina Napso; Xiaohui Zhao; Marta Ibañez Lligoña; Ionel Sandovici; Richard G Kay; Amy L George; Fiona M Gribble; Frank Reimann; Claire L Meek; Russell S Hamilton; Amanda N Sferruzzi-Perri
Journal:  Commun Biol       Date:  2021-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.